A Stony Science: Making Cholesterol 'Glow' May Shed Light On Gallstones And Other Ailments, UD Prof Says

November 18, 1998

Using a 'glowing twin' of cholesterol and other bile components, chemical engineers at the University of Delaware--working with a doctor at the University of Washington School of Medicine--have characterized the behavior of an enzyme known to speed the growth of gallstones, which affect some 20 million Americans.

The system for studying bile chemistry may someday help geneticists pinpoint and perhaps even turn off the genes responsible for gallstone formation, a disorder associated with more than $5 billion in medical costs each year, says Eric Kaler, chairperson of UD's Department of Chemical Engineering and the University?s Elizabeth Inez Kelley Professor of Chemical Engineering.

And, the UD technique may suggest new strategies for investigating a host of other problems involving cholesterol--particularly cardiovascular ailments, says Kaler's graduate student, Steven Parker Wrenn.

"Within a synthetic bile system, we can pinpoint the onset of nucleation--a preliminary step in gallstone formation, which no one has previously been able to measure," Wrenn reported Nov. 18 during the American Institute of Chemical Engineers (AIChE) 1998 annual meeting in Miami. "Our technique is not intended to be used by doctors as a diagnostic tool for treating patients," Wrenn emphasizes, "but rather, as a way to identify the proteins that speed or slow the formation of crystalline gallstone precursors."

In collaboration with Sum P. Lee, M.D., of the University of Washington School of Medicine--one of "The Best Doctors in America," according to a 1998 survey by Woodward/White, Inc. of South Carolina--Kaler and Wrenn devised a system for detecting changes in the fluorescence energy of 'twins' or analogs for cholesterol and lecithin, two components of bile.

The research team has so far investigated the enzyme, phospholipase C, known to be a key stone-forming factor. (A forthcoming article in a peer-reviewed journal will describe the group's research in detail, Wrenn says.)

Understanding gallstones

Gallstones affect an estimated 10 to 15 percent of the population, according to the National Institutes of Health. Most gallstones, composed mainly of hardened cholesterol clusters, are smaller than 2 centimeters in diameter--slightly smaller than an inch--and some patients never develop symptoms. But gallstones can cause serious problems, ranging from chronic pain and pancreas damage to blocked ducts requiring surgery and an increased risk of gallbladder cancer, the NIH has reported.

How do gallstones form? After a meal, Wrenn explains, hormones prompt the gallbladder to release bile into the gastrointestinal tract. Produced in the liver and stored downstream in the gallbladder, this yellow-brown fluid breaks down fats, and it helps the body absorb fat-soluble vitamins such as A, D, E and K.

Because water can't dissolve cholesterol, it must be delivered to the gastrointestinal tract inside carrier structures--mainly fluid-filled spheres or "vesicles" made from lecithin. A waxy substance found in egg yolks, lecithin "self-assembles," or curls up to form tiny spheres within bile, Wrenn says.

A second cholesterol carrier within bile is a rod-like cluster of bile salt molecules known as a micelle. Unfortunately, micelles prefer to dissolve lecithin, and tend to dissolve more lecithin than cholesterol. The action of micelles, therefore, results in cholesterol-enriched vesicles, which are prone to nucleation. Various proteins also affect the rate at which cholesterol "nucleates" or leaves the lecithin spheres, Wrenn says.

"Once cholesterol clusters reach a critical size," Wrenn notes, "they are considered to be a nucleus. At that point, the nucleus can only grow larger. It will never again dissolve back to free cholesterol. It will grow and eventually crystallize, sometimes resulting in macroscopic gallstones."

Pinpointing growth factors

Within the rich, chemical broth of bile, a number of proteins are believed to either promote or slow cholesterol nucleation and, therefore, gallstone growth. Clinicians describe these enzymes as "pro-nucleating" or "anti-nucleating" factors, Wrenn says.

To identify the key players in gallstone formation, UD researchers developed a system for observing the interactions of cholesterol and lecithin within artificial bile, a complex soup synthesized in Kaler's laboratory. Specifically, they "tagged" the two molecules with a pair of naturally glowing (fluorescent) analogs: dehydroergosterol, a chemical twin for cholesterol; and dansylated lecithin, which resembles the lecithin molecule found in bile. ("Dansyl" is an acronym for DimethylAminoNaphthalene-Sulfonyl.)

Whenever these glowing, analog molecules come within 50 nanometers of each other--a distance equivalent to the diameter of a typical lecithin sphere--they undergo a process of energy transfer, Wrenn explains. Using a spectrometer to detect ultraviolet light, the UD researchers could "see" cholesterol leaving lecithin vesicles, based on changes in the extent of the energy transfer between the two analog molecules. An increase in the dehydroergosterol signal, coupled with a decrease in the dansylated lecithin signal, told the researchers that cholesterol had nucleated.

As expected, introducing phopholipase C to the sample dramatically increased nucleation speeds. The enzyme seems to accelerate the process, through a chemical reaction involving calcium, which forms diacylglycerol on the outer layer of the lecithin vesicle. Because diacylglycerol doesn't dissolve in water, resulting vesicles more rapidly form cholesterol-rich clusters.

Phospholipase C has long been known to promote gallstone growth, Wrenn says, but the new UD technique made it possible to better understand the enzyme's chemical function and behavior. And, the UD technique gave researchers their first glimpse of nucleation events in process.

Support for this research was provided by Grant RO1 DK41678 from the National Institutes of Health. Lee's work also is supported in part by the Medical Research Service of the Department of Veterans Affairs.
NOTE: This news release describes a presentation scheduled to take place at 11 a.m. Wednesday, Nov. 18, in Miami's Fountainebleau Hilton/Eden Roc Hotel (Lorraine-Font H room), as part of the American Institute of Chemical Engineers 1998 annual meeting.
Contacts: UD--Ginger Pinholster 302-831-6408, gingpin@udel.edu; UW--Laurie McHale 206-543-3620, lmchale@u.washington.edu

University of Delaware

Related Cholesterol Articles from Brightsurf:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.

Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.

Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.

Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.

New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.

Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.

Read More: Cholesterol News and Cholesterol Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.